Ueno T - Search Results

1

Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy.

Olofsson MH, Ueno T, Pan Y, Xu R, Cai F, van der Kuip H, Muerdter TE, Sonnenberg M, Aulitzky WE, Schwarz S, Andersson E, Shoshan MC, Havelka AM, Toi M, Linder S. Olofsson MH, et al. Among authors: ueno t. Clin Cancer Res. 2007 Jun 1;13(11):3198-206. doi: 10.1158/1078-0432.CCR-07-0009. Clin Cancer Res. 2007. PMID: 17545523

2

A novel high-through-put assay for screening of pro-apoptotic drugs.

Hägg M, Bivén K, Ueno T, Rydlander L, Björklund P, Wiman KG, Shoshan M, Linder S. Hägg M, et al. Among authors: ueno t. Invest New Drugs. 2002 Aug;20(3):253-9. doi: 10.1023/a:1016249728664. Invest New Drugs. 2002. PMID: 12201488

3

Processing of pulmonary surfactant protein B by napsin and cathepsin H.

Ueno T, Linder S, Na CL, Rice WR, Johansson J, Weaver TE. Ueno T, et al. J Biol Chem. 2004 Apr 16;279(16):16178-84. doi: 10.1074/jbc.M312029200. Epub 2004 Feb 6. J Biol Chem. 2004. PMID: 14766755 Free article.

4

A close association between alteration in growth kinetics by neoadjuvant chemotherapy and survival outcome in primary breast cancer.

Takada M, Kataoka A, Toi M, Bando H, Toyama K, Horiguchi S, Ueno T, Linder S, Saji S, Hayashi Y, Funata N, Kinoshita J, Murakami S, Ohono S. Takada M, et al. Among authors: ueno t. Int J Oncol. 2004 Aug;25(2):397-405. Int J Oncol. 2004. PMID: 15254737

5

Determining tumor apoptosis and necrosis in patient serum using cytokeratin 18 as a biomarker.

Linder S, Havelka AM, Ueno T, Shoshan MC. Linder S, et al. Among authors: ueno t. Cancer Lett. 2004 Oct 8;214(1):1-9. doi: 10.1016/j.canlet.2004.06.032. Cancer Lett. 2004. PMID: 15331168 Review.

6

The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.

Ueno T, Elmberger G, Weaver TE, Toi M, Linder S. Ueno T, et al. Lab Invest. 2008 Mar;88(3):256-63. doi: 10.1038/labinvest.3700718. Epub 2008 Jan 14. Lab Invest. 2008. PMID: 18195689 Free article.

7

[A case of primary breast cancer who responded remarkably to the neoadjuvant chemotherapy with the combination of docetaxel and cyclophosphamide].

Yoshibayashi H, Ishiguro H, Takada M, Takeuchi M, Yamashiro H, Ueno T, Kato H, Yoshikawa K, Kanao S, Yamauchi C, Mikami Y, Toi M. Yoshibayashi H, et al. Among authors: ueno t. Gan To Kagaku Ryoho. 2008 Jun;35(6):987-90. Gan To Kagaku Ryoho. 2008. PMID: 18633230 Japanese.

8

[Biomarker].

Ueno T, Toi M. Ueno T, et al. Gan To Kagaku Ryoho. 2009 Jan;36(1):15-20. Gan To Kagaku Ryoho. 2009. PMID: 19151560 Japanese.

9

Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients.

Chanplakorn N, Chanplakorn P, Suzuki T, Ono K, Chan MS, Miki Y, Saji S, Ueno T, Toi M, Sasano H. Chanplakorn N, et al. Among authors: ueno t. Breast Cancer Res Treat. 2010 Apr;120(3):639-48. doi: 10.1007/s10549-010-0785-3. Epub 2010 Feb 12. Breast Cancer Res Treat. 2010. PMID: 20151319

10

Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population.

Toi M, Iwata H, Yamanaka T, Masuda N, Ohno S, Nakamura S, Nakayama T, Kashiwaba M, Kamigaki S, Kuroi K; Japan Breast Cancer Research Group-Translational Research Group. Toi M, et al. Cancer. 2010 Jul 1;116(13):3112-8. doi: 10.1002/cncr.25206. Cancer. 2010. PMID: 20564629 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,529 results

Search Page

Filters